<bill session="116" type="s" number="724" updated="2019-10-23T04:00:22Z">
  <state datetime="2019-03-07">REFERRED</state>
  <status>
    <introduced datetime="2019-03-07"/>
  </status>
  <introduced datetime="2019-03-07"/>
  <titles>
    <title type="official" as="introduced">A bill to amend the Controlled Substances Act to establish additional registration requirements for prescribers of opioids, and for other purposes.</title>
    <title type="short" as="introduced">John S. McCain Opioid Addiction Prevention Act</title>
    <title type="short" as="introduced">John S. McCain Opioid Addiction Prevention Act</title>
    <title type="display">John S. McCain Opioid Addiction Prevention Act</title>
  </titles>
  <sponsor bioguide_id="G000555"/>
  <cosponsors>
    <cosponsor bioguide_id="G000562" joined="2019-03-07"/>
  </cosponsors>
  <actions>
    <action datetime="2019-03-07">
      <text>Introduced in Senate</text>
    </action>
    <action datetime="2019-03-07" state="REFERRED">
      <text>Read twice and referred to the Committee on the Judiciary.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="SSJU" name="Senate Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="116" relation="identical" number="1614"/>
  </relatedbills>
  <subjects>
    <term name="Crime and law enforcement"/>
    <term name="Drug therapy"/>
    <term name="Drug trafficking and controlled substances"/>
    <term name="Drug, alcohol, tobacco use"/>
    <term name="Health personnel"/>
    <term name="Licensing and registrations"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2019-03-07T05:00:00Z" status="Introduced in Senate">John S. McCain Opioid Addiction Prevention Act

This bill establishes a new registration requirement for practitioners who are licensed to prescribe controlled substances in schedule II, III, or IV.

Specifically, a practitioner must agree to limit the supply of opioids prescribed for the initial treatment of acute pain, as a condition of obtaining or renewing a registration through the Drug Enforcement Administration.

An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.</summary>
  <committee-reports/>
</bill>
